Pharmaceutical

  • Government defends move to cap condom prices 25-03-2014 10:49 PM

    New Delhi: The central government on Tuesday defended its decision to bring condoms under the Drug Price Control Order (DPCO), which has put a cap on prices of all male contraceptives in the country. Delhi High Court's acting Chief Justice BD Ahmed and Justice Sidharth Mridul was also informed by...
  • Ranbaxy suspends drug ingredients shipment from 2 plants 25-02-2014 09:51 AM

    Tokyo: Drugmaker Ranbaxy Laboratories Ltd on Tuesday said it has suspended all shipments of pharmaceutical ingredients produced at two local factories to review processes and controls. The Toansa and Dewas plants are currently banned from shipping products to the United States following quality concerns, so the suspension will hit supplies...
  • Major pharmaceutical firm under scrutiny for producing spurious drugs 17-10-2013 09:53 AM

    Ambala: Fake drugs are one of India's worst kept secrets. Almost 45 per cent of drugs distributed in the country are manufactured in Himachal Pradesh and a major company based in the state, Vardhaman Pharmaceuticals, is under scrutiny for producing and distributing spurious drugs across the country. Filthy machines prepare...
  • Vardhman Pharmaceuticals under scanner for producing spurious drugs 16-10-2013 09:13 PM

    Shimla: Vardhaman Pharmaceuticals, a private company in Himachal Pradesh, is under scanner for producing spurious drugs. CNN-IBN has accessed details showing how the company is producing spurious drugs. The licence of Vardhaman Pharmaceuticals lapsed in 2009. The company manufactured fake drugs and labelled them with the government supply stickers. These...
  • No clinical trial of untested drugs in absence of mechanism: Supreme Court 30-09-2013 01:06 PM

    No clinical trials should be allowed for new drugs till a mechanism is put in place to monitor them and to protect the lives of people on which drugs are tested, the Supreme Court on Monday said. A bench headed by Justice RM Lodha said that a system must be...
  • Government will soon finalise FDI policy on pharma sector: Chidambaram 13-08-2013 01:57 AM

    Finance Minister P Chidambaram on Monday said the government will soon finalise the foreign investment policy on brownfield pharmaceutical projects, paving the way for clearance of held-up proposals. "...I believe the discussion (with regard to FDI in brownfield pharmaceuticals) between the Ministry of Commerce and Prime Minister and others is...
  • SC to hear PIL on the pricing of drugs in India 05-08-2013 11:00 AM

    New Delhi: The Supreme Court on Monday will hear a PIL by the pharma companies on the pricing of medicines in India. The PIL was filed by four pharma firms who challenged the Delhi High Court's order to reduce the prices of certain medicines. These pharma companies were also asked...
  • Clinical trial of untested drugs must be regulated: SC 26-07-2013 05:56 PM

    New Delhi: Clinical trials of untested drugs on humans require certain mandatory standards to be followed, the Supreme Court said on Friday while directing the government to put in place a mechanism to monitor them. The apex court directed the Centre to convene a meeting of Chief Secretaries or Health...
  • 9 pharmaceutical companies fined Rs 2500 cr for overcharging 19-07-2013 05:08 PM

    New Delhi: Nine pharmaceutical companies have been fined Rs 2500 crore by the National Pharmaceutical Pricing Authority (NPPA) for overcharging customers. The NPPA imposed penalty after the drug makers, which also include Ranbaxy, Dr. Reddy's Lab, Glenmark, Cipla and Cadilla, were overcharging patients on Doxofylline. The asthma drug was being...
  • India ready to discuss patent policies with US lawmakers 26-06-2013 07:45 AM

    Washington: Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, Indian Ambassador to the United States, Nirupama Rao, offered concerned lawmakers to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries. "My senior colleagues at the...
  • A company can't depend on one person: Dr Reddy's Labs' GV Prasad 17-06-2013 11:51 AM

    New Delhi: When I came back to India after graduation in the US, I knew I wanted to start a business but what that would be I didn't know. I joined the family business for a while and then set up a bulk drugs company, Benzex Labs, with my parents'...
  • US businesses complain about India trade practices 06-06-2013 12:45 AM

    Washington: Leading US business groups on Wednesday urged President Barack Obama to act against what they said were "unacceptable" Indian trade practices that have hurt US exports in areas ranging from pharmaceuticals to electronics. The National Association of Manufacturers and other business groups expressed their concerns in a letter that...
  • EU to fine Ranbaxy, others for blocking generic drugs 04-06-2013 10:14 AM

    Brussels: A European regulator will fine Denmark's Lundbeck, India's Ranbaxy and seven other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals. Following an inquiry launched in 2009, the European Union's anti-trust regulator will...
  • Patent row: Delhi HC to hear diabetes drug case 23-05-2013 10:15 AM

    New Delhi: The patent battle between US pharmaceuticals major Merck Sharp and Dohme (MSD) and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. Indian pharma company Glenmark recently came out with generic versions of Merck's type-2...
  • Drug prices to be slashed as pricing policy comes into effect 17-05-2013 08:46 PM

    From July, more than 300 essential medicines will cost 20 to 25 per cent less, as the new national pricing policy comes into effect. How will this affect us and why are some calling it an eyewash? ...
  • Ranbaxy fined $ 500 mn for selling adulterated drugs 14-05-2013 08:30 AM

    New Delhi: Generic drugmaker Ranbaxy has been fined $500 million by the US government after its subsidiary pleaded guilty to sale of adulterated drugs manufactured in India. It is the largest settlement by a generic medicine maker till date. It includes $150 million in payments for a criminal fine and...
  • Railway Board bribery case: Decoding the Bansal empire 07-05-2013 10:12 PM

    Pawan Kumar Bansal is under fire over bribery charges against his nephew Vijay Singhla, who is also one of the directors of Jagan Realtors Private Limited, which has several other relatives of Bansal on board. ...
  • Railway scam: BJP trains guns on Bansal family's pharmaceutical company 07-05-2013 07:13 PM

    The BJP has now claimed Theon Pharmaceuticals was involved in price fixing. Pawan Kumar Bansal's wife Madhu Bansal, sons Manish Bansal and Amit Bansal are directors in Theon Pharmaceuticals. ...
  • US: NY lawsuit accuses Novartis of healthcare fraud 24-04-2013 09:00 AM

    New York: The US government has sued Novartis Pharmaceuticals Corp, claiming it gave kickbacks to pharmacies to switch kidney transplant patients from competitors' drugs to its own. The civil health care fraud lawsuit in US District Court in Manhattan seeks unspecified damages and civil penalties for a scheme that the...
  • Patent row: HC refuses interim relief to Merck 05-04-2013 05:54 PM

    New Delhi: The Delhi High Court on Friday refused to grant interim relief on a patent row to US pharmaceuticals major Merck Sharp and Dohme (MSD) which sought a restraint on Indian firm Glenmark Pharmaceuticals manufacturing and marketing anti-diabetes drugs Zita and Zita-Met. Justice Rajiv Sahai Endlaw dismissed the interim...
  • Novartis cannot ignore India's huge market: Indian Pharmaceutical Alliance 01-04-2013 09:15 PM

    The secretary general of the Indian Pharmaceutical Alliance, DG Shah said that Novartis was merely posturing and it could not ignore the huge market that India provided to its products. ...
  • Cipla appoints Subhanu Saxena as new CEO 22-11-2012 09:16 AM

    Bangalore: Drug-maker Cipla on Thursday said it has appointed Subhanu Saxena as the Chief Executive Officer of the company. The appointment is effective from February 1, 2013. Saxena has more than 25 years of work experience. He has worked with companies such as Citicorp, The Boston Consulting Group and PepsiCo,...